cellulose sulfate has been researched along with HIV Infections in 26 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 17 (65.38) | 29.6817 |
| 2010's | 8 (30.77) | 24.3611 |
| 2020's | 1 (3.85) | 2.80 |
| Authors | Studies |
|---|---|
| Mwethera, PG; Obiero, J; Ogongo, P; Wiysonge, CS | 1 |
| Archer, DF; Callahan, MM; Chandra, N; Creinin, MD; Dezzutti, CS; Doncel, GF; Fichorova, RN; Hillier, SL; Lai, JJ; Mauck, CK; Schwartz, JL; Weiner, DH | 1 |
| D'Andrea, A; Fields, S; Fong, J; Mirsalis, J; Rasoul, B; Shew, K; Song, B; Works, MG; Yiu, Y | 1 |
| Hamer, D; Richards, C; Tao, W | 1 |
| Alary, M; Becker, ML; Crucitti, T; Deese, J; Govinden, R; Guédou, F; Krishnan, AK; Mirembe, FM; Pande, B; Pradeep, BS; Ramjee, G; Solomon, S; Taylor, D; Van Damme, L | 1 |
| Neurath, AR | 1 |
| Abdellati, S; Crucitti, T; Halpern, V; McNeil, L; Mehta, N; Obunge, O; Oduyebo, O; Ogunsola, F; Onyejepu, N; Otusanya, S; Taylor, D; Umo-Otong, J; Wang, CH | 1 |
| Chang, TL; Ding, J; Klotman, ME; Lu, W; Rapista, A; Teleshova, N | 1 |
| Ampofo, W; Feldblum, PJ; Halpern, V; Lie, CC; Obunge, O; Ogunsola, F; Opoku, K | 1 |
| Buyze, J; Goetghebeur, E | 1 |
| Beelaert, G; Crucitti, T; Fransen, K; Taylor, D; Van Damme, L | 1 |
| Mwethera, PG; Obiero, J; Wiysonge, CS | 1 |
| Ben, Y; Li, L; Li, W; Xu, J; Zhang, X; Zhu, Z | 1 |
| Absalon, J; El-Sadr, WM; Gai, F; Hoesley, C; Justman, J; Kwiecien, A; Maslankowski, L; Mâsse, B; Mauck, C; Mayer, KH; Morrow, K; Soto-Torres, L | 1 |
| Buvé, A; Jespers, V; Van Damme, L | 1 |
| Moszynski, P | 1 |
| Check, E | 1 |
| Honey, K | 1 |
| Govinden, R; Mbewu, A; Morar, NS; Ramjee, G | 1 |
| Moodley, K | 1 |
| Shattock, RJ; van de Wijgert, JH | 1 |
| Albrecht, H | 1 |
4 review(s) available for cellulose sulfate and HIV Infections
| Article | Year |
|---|---|
Topical microbicides for preventing sexually transmitted infections.
Topics: Acrylic Resins; Adenine; Administration, Intravaginal; Agaricales; Anti-HIV Agents; Anti-Infective Agents, Local; Bias; Cellulose; Female; HIV Infections; Humans; Naphthalenesulfonates; Placebos; Polymers; Pyrimidines; Seaweed; Sexually Transmitted Diseases; Tenofovir | 2021 |
Topical microbicides for prevention of sexually transmitted infections.
Topics: Acrylic Resins; Adenine; Administration, Topical; Agaricales; Anti-HIV Agents; Anti-Infective Agents, Local; Cellulose; Female; HIV Infections; Humans; Male; Naphthalenesulfonates; Organophosphonates; Polymers; Seaweed; Sexually Transmitted Diseases; Tenofovir | 2012 |
Phase III anti-HIV microbicide trial in Africa and India stopped as preliminary results show gel may increase risk of infection.
Topics: Africa; Anti-HIV Agents; Anti-Infective Agents, Local; Cellulose; Clinical Trials, Phase III as Topic; Female; Gels; HIV Infections; Humans; India; Risk Factors | 2007 |
Vaginal microbicides: moving ahead after an unexpected setback.
Topics: Administration, Intravaginal; Anti-HIV Agents; Cellulose; Clinical Trials as Topic; Disease Susceptibility; Female; HIV Infections; HIV-1; Humans; Vagina; Vaginal Creams, Foams, and Jellies | 2007 |
7 trial(s) available for cellulose sulfate and HIV Infections
| Article | Year |
|---|---|
Toward early safety alert endpoints: exploring biomarkers suggestive of microbicide failure.
Topics: Adult; Anti-Infective Agents; Biomarkers; Cellulose; Double-Blind Method; Female; HIV Infections; Humans; Middle Aged; Nonoxynol; Placebos; Treatment Failure; Vagina; Vaginitis; Young Adult | 2013 |
Lack of effectiveness of cellulose sulfate gel for the prevention of vaginal HIV transmission.
Topics: Administration, Intravaginal; Adult; Anti-HIV Agents; Cellulose; Chlamydia Infections; Disease Transmission, Infectious; Double-Blind Method; Female; Gels; Gonorrhea; HIV Infections; Humans; Kaplan-Meier Estimate; Placebos; Sexual Behavior; Treatment Failure | 2008 |
Effectiveness of cellulose sulfate vaginal gel for the prevention of HIV infection: results of a Phase III trial in Nigeria.
Topics: Adolescent; Adult; Cellulose; Chlamydia Infections; Coitus; Condoms; Double-Blind Method; Female; Gonorrhea; HIV Infections; Humans; Male; Nigeria; Safety; Treatment Outcome; Vaginal Creams, Foams, and Jellies; Young Adult | 2008 |
Performance of a rapid and simple HIV testing algorithm in a multicenter phase III microbicide clinical trial.
Topics: AIDS Serodiagnosis; Algorithms; Antiviral Agents; Cellulose; Double-Blind Method; Female; HIV Antibodies; HIV Infections; HIV-1; HIV-2; Humans; Mass Screening; Polymerase Chain Reaction; Reagent Kits, Diagnostic; RNA, Viral; Sensitivity and Specificity; Time Factors; Treatment Outcome | 2011 |
Safety and acceptability of cellulose sulfate as a vaginal microbicide in HIV-infected women.
Topics: Abdominal Pain; Adolescent; Adult; Anti-HIV Agents; Cellulose; Double-Blind Method; Female; HIV Infections; Humans; Hydrogen-Ion Concentration; Male; Metrorrhagia; Middle Aged; Patient Compliance; Patient Satisfaction; Sexual Abstinence; Vaginal Creams, Foams, and Jellies | 2006 |
Safety trial of the vaginal microbicide cellulose sulfate gel in HIV-positive men.
Topics: Administration, Cutaneous; Adult; Anti-Infective Agents; Cellulose; Double-Blind Method; Gels; HIV Infections; Humans; Male; Middle Aged; Penis; Sexually Transmitted Diseases; Treatment Outcome | 2007 |
Microbicide trial screeches to a halt.
Topics: Anti-HIV Agents; Anti-Infective Agents, Local; Cellulose; Double-Blind Method; Female; HIV Infections; Humans | 2007 |
15 other study(ies) available for cellulose sulfate and HIV Infections
| Article | Year |
|---|---|
New candidate biomarkers in the female genital tract to evaluate microbicide toxicity.
Topics: Administration, Intravaginal; Animals; Anti-Infective Agents; Benzalkonium Compounds; Biomarkers; Cellulose; Cytokines; Female; Gene Expression Regulation; Genitalia, Female; Granulocyte Colony-Stimulating Factor; HIV Infections; Humans; Mice; Mucin-5B; Nonoxynol; Rabbits; Vagina | 2014 |
Enhancement of HIV infection by cellulose sulfate.
Topics: Anti-HIV Agents; Cells, Cultured; Cellulose; Clinical Trials as Topic; Dose-Response Relationship, Drug; HIV Infections; HIV-1; Humans; Leukocytes, Mononuclear; Virus Replication | 2008 |
Cellulose sulfate for prevention of HIV infection.
Topics: Administration, Intravaginal; Anti-HIV Agents; Cellulose; Disease Transmission, Infectious; Female; HIV Infections; Humans; Hydrogen-Ion Concentration; Treatment Failure; Vagina | 2008 |
Mucosal human defensins 5 and 6 antagonize the anti-HIV activity of candidate polyanion microbicides.
Topics: Anti-HIV Agents; Anti-Infective Agents; Carrageenan; CD4-Positive T-Lymphocytes; Cellulose; Defensins; Female; HeLa Cells; HIV Infections; HIV-1; Humans; Immunity, Innate; Mucous Membrane; Naphthalenesulfonates; Polyelectrolytes; Polymers; Vagina | 2011 |
What predicts non-retention in microbicide trials?
Topics: Adolescent; Adult; Africa South of the Sahara; Age Factors; Anti-Infective Agents, Local; Betaine; Cellulose; Early Termination of Clinical Trials; Fatty Acids, Unsaturated; Female; HIV Infections; Humans; Patient Dropouts; Proportional Hazards Models; Randomized Controlled Trials as Topic; Socioeconomic Factors; Vaginal Creams, Foams, and Jellies; Young Adult | 2011 |
Crossover studies with survival outcomes.
Topics: Cellulose; Cross-Over Studies; HIV Infections; Humans; Models, Theoretical; Nonoxynol; Survival Analysis | 2013 |
Minocycline down-regulates topical mucosal inflammation during the application of microbicide candidates.
Topics: Animals; Anti-Bacterial Agents; Anti-Infective Agents; CD4-Positive T-Lymphocytes; Cellulose; Down-Regulation; Drug Evaluation, Preclinical; Female; Gels; HIV Infections; Inflammation; Mice; Mice, Inbred BALB C; Minocycline; Mucous Membrane; Vagina | 2012 |
Africa, India test sites for anti-HIV microbicide. Cellulose sulfate tested in high-risk women.
Topics: Africa; Anti-HIV Agents; Cellulose; Clinical Trials, Phase III as Topic; Female; HIV Infections; Humans; India; Power, Psychological; Risk Factors | 2005 |
Vaginal gel effective.
Topics: Anti-HIV Agents; Cellulose; Female; HIV Infections; Humans; Male; Patient Satisfaction; Spermatocidal Agents; Vaginal Creams, Foams, and Jellies | 2006 |
Halt to microbicide trial sets back AIDS research.
Topics: Anti-Infective Agents; Cellulose; Clinical Trials, Phase III as Topic; Female; HIV Infections; Humans; Infant | 2007 |
Newer approaches to HIV prevention.
Topics: Cellulose; Circumcision, Male; Female; HIV Infections; Humans; Kenya; Male; Randomized Controlled Trials as Topic; Uganda | 2007 |
Scientists rethink approach to HIV gels.
Topics: Anti-Infective Agents; Cellulose; Clinical Trials, Phase III as Topic; Female; Gels; HIV Infections; Humans; Male; Research Design; Treatment Failure | 2007 |
South Africa's experience of the closure of the cellulose sulphate microbicide trial.
Topics: Anti-Infective Agents; Cellulose; Female; Gels; Geography; HIV Infections; Humans; Male; Patient Compliance; Practice Guidelines as Topic; Randomized Controlled Trials as Topic; South Africa; Treatment Outcome | 2007 |
Microbicide research in developing countries: have we given the ethical concerns due consideration?
Topics: Adolescent; AIDS Vaccines; Anti-HIV Agents; Biomedical Research; Cellulose; Clinical Trials, Phase III as Topic; Condoms; Developing Countries; Ethics Committees, Research; Ethics, Research; Female; Health Services Accessibility; HIV Infections; HIV Seropositivity; Humans; Infectious Disease Transmission, Vertical; Informed Consent; Male; Moral Obligations; Nonoxynol; Pregnancy; Pregnancy Complications, Infectious; Research Design; Research Personnel; Research Subjects; Risk Assessment; Sexual Partners; South Africa; Vulnerable Populations | 2007 |
Report from the 4th IAS Conference on HIV Pathogenesis, Treatment and Prevention. Disappointing data from anti-HIV microbicide trials.
Topics: Administration, Topical; Anti-HIV Agents; Cellulose; HIV Infections; Humans; Male; Sexual Partners | 2007 |